Polen Capital Abbott Laboratories Transaction History
Polen Capital Management LLC
- $43.3 Billion
- Q1 2024
A detailed history of Polen Capital (Polen Capital Management LLC) transactions in Abbott Laboratories stock. As of the latest transaction made, Polen Capital Management LLC holds 16,141,237 shares of ABT stock, worth $1.68 Billion. This represents 4.24% of its overall portfolio holdings.
Number of Shares
16,141,237
Previous 13,488,308
19.67%
Holding current value
$1.68 Billion
Previous $1.48 Billion
23.57%
% of portfolio
4.24%
Previous 3.57%
Shares
20 transactions
Others Institutions Holding ABT
# of Institutions
3,122Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$17.2 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.9 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.74 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.78 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.3 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $182B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...